Fountain Healthcare Partners

Total investments

48

Average round size

29M

Portfolio companies

26

Rounds per year

3.00

Lead investments

13

Follow on index

0.46

Exits

7

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
Therapeutic DevicesBiotechnologyHealth CareMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharmaClinical TrialsEmergency Medicine

Summary

The leading representative office of defined VC is situated in the Dublin. The fund was located in Europe if to be more exact in Ireland.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Fountain Healthcare Partners, startups are often financed by Enterprise Ireland, Seroba Life Sciences, Longitude Capital. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, Novartis Venture Fund, Longitude Capital. In the next rounds fund is usually obtained by Enterprise Ireland, Sunstone Life Science Ventures, Roche Venture Fund.

Among the various public portfolio startups of the fund, we may underline Inflazome, Opsona, Amarin For fund there is a match between the country of its foundation and the country of its the most frequent investments - Ireland. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Biopharma. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The current fund was established by Aidan King, Manus Rogan. The overall number of key employees were 4.

The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations. When the investment is from Fountain Healthcare Partners the average startup value is 50-100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. Comparing to the other companies, this Fountain Healthcare Partners performs on 10 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Show more

Investments analytics

Analytics

Total investments
48
Lead investments
13
Exits
7
Rounds per year
3.00
Follow on index
0.46
Investments by industry
  • Health Care (40)
  • Biotechnology (36)
  • Medical (27)
  • Medical Device (23)
  • Therapeutics (11)
  • Show 12 more
Investments by region
  • Ireland (27)
  • United States (7)
  • Italy (3)
  • Belgium (4)
  • United Kingdom (3)
  • Show 2 more
Peak activity year
2018

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
57M
Group Appearance index
0.90
Avg. company exit year
7
Avg. multiplicator
6.33
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
MMI 21 Feb 2024 Health Care, Robotics, Medical Device, Medical Late Stage Venture 110M Tuscany, Italy, Italy
Syndesi Therapeutics 28 Sep 2020 Biotechnology, Health Care Early Stage Venture 7M Limburg, Belgium, Belgium

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.